WeVote
Log In

Bill

Bill

A 1908

Requires health care providers and practitioners to provide patients with a list of ingredients contained in vaccines

2025 Regular Session Introduced by Dave DiPietro

Requires health care providers to give patients a list of vaccine ingredients to boost transparency and informed consent, with no specified timing, format, or enforcement.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · A 1908

Summary of Bill A 1908

Overview

  • Bill Number: A 1908
  • Title: Requires health care providers and practitioners to provide patients with a list of ingredients contained in vaccines
  • Status: REFERRED TO HEALTH
  • Introduced: January 14, 2025
  • Sponsor: David DiPietro (primary)
  • Related bills (prior-session): A 9609, A 5236, A 4900

Purpose and Intent

  • The bill aims to increase transparency around vaccines by requiring health care providers and practitioners to furnish patients with a list of vaccine ingredients. This is intended to support informed decision-making and patient awareness regarding vaccines.

Key Provisions

  • Providers and practitioners Scope: Applies to health care providers and practitioners who administer vaccines.
  • Ingredient Disclosure: Requires a list of ingredients contained in vaccines to be provided to patients.
  • Timing and manner: Publicly available information does not specify exact timing (e.g., before or at the point of administration) or format (written, electronic, or both). The available information indicates the obligation to provide the list but does not detail procedural requirements.
  • Enforcement and penalties: No enforcement provisions are specified in the summarized information.

Affected Parties

  • Patients receiving vaccines: Recipients would receive a list of vaccine ingredients.
  • Health care providers and practitioners: Responsible for providing the ingredient list to patients.
  • Health care facilities and settings where vaccines are administered (potentially impacted by new disclosure practices).

Procedural and Timeline Aspects

  • The bill was introduced on January 14, 2025 and immediately referred to the Health committee, indicating early-stage consideration.
  • The legislative actions show two identical “REFERRED TO HEALTH” entries on the same date, suggesting a routine referral; no further committee actions are listed.

Related Legislation

  • A 9609, A 5236, A 4900 (prior-session): Indicate ongoing interest in vaccine transparency and related public health provisions in earlier sessions.

Potential Impacts and Considerations

  • Transparency and Informed Consent: Could enhance patient knowledge about vaccine ingredients, supporting informed consent processes.
  • Administrative Burden: May require clinics and providers to adjust workflows to supply ingredient lists, with potential printing or electronic distribution costs.
  • Accessibility: Consideration of language translation and accessibility to ensure all patients receive comprehensible ingredient information.
  • Open Questions: The provided summary does not specify format, timing, exemptions (e.g., emergency situations), enforcement mechanisms, or penalties for noncompliance. Further detail from the bill text would clarify these elements.

Summary

A 1908 proposes a straightforward transparency measure requiring vaccine ingredient disclosure to patients by health care providers and practitioners. It is in the early stages of the legislative process (referral to Health) with related prior-session bills suggesting a broader interest in vaccine ingredient transparency.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.